Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse

Francesco Tona1, Elisabetta Zanatta2, Roberta Montisci3

  • 1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, 35128 Padova, Italy.

Insights

Systemic sclerosis (SSc) patients may have impaired ventricular-arterial coupling (VAC) even without overt heart disease. Higher VAC predicts a greater risk of major adverse cardiovascular events (MACE) in SSc.

Area of Science:

  • Cardiology
  • Rheumatology
  • Biomedical Engineering

Background:

  • Primary myocardial involvement is frequent in systemic sclerosis (SSc).
  • Ventricular-arterial coupling (VAC) is crucial for cardiovascular (CV) performance, linking ventricular function and arterial load.
  • Altered VAC may precede detectable cardiac dysfunction in SSc.

Purpose of the Study:

  • To investigate VAC and related indices in SSc patients without primary myocardial involvement.
  • To explore the association between altered VAC and survival free from major adverse CV events (MACE) in SSc.

Main Methods:

  • Cross-sectional study comparing 65 SSc patients (without cardiac evidence) to healthy controls.
  • Three-dimensional echocardiography (3DE) for noninvasive measurement of end-systolic elastance (Ees), arterial elastance (Ea), and VAC (Ea/Ees).
  • Median 4-year follow-up for MACE (death/hospitalization).

Main Results:

  • SSc patients exhibited higher Ees, Ea, and end-diastolic elastance (Eed) than controls, with similar VAC.
  • Diffuse cutaneous SSc (dcSSc) showed lower Ees and higher VAC compared to limited cutaneous SSc (lcSSc).
  • VAC > 0.63 was associated with a 2.5-fold increased risk of MACE and reduced event-free survival (p=0.005).

Conclusions:

  • Ventricular-arterial coupling may be subtly impaired in SSc patients even before clinical signs of cardiac involvement.
  • VAC serves as a potential prognostic biomarker for cardiovascular events in systemic sclerosis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
100
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
112
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
141
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
104
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
533
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
432